UNSPSC 51393702: Pelrinone

This classification denotes a phosphodiesterase inhibitor with the molecular formula C12H11N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9XK91ZI6I5, chemically known as 2-methyl-4-oxo-6-(pyridin-3-ylmethylamino)-1H-pyrimidine-5-carbonitrile but generally known as pelrinone, which bears US NIH Compound Identifier 55920. European Medicines Agency schedules pelrinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09651MIG. Most nations schedule pelrinone under HS 29335995 and SITC 51576.

As of Q4 2014, PELRINONE remains the US FDA Preferred Term for this commodity. SMILES: CC1=NC(=O)C(=C(N1)NCC2=CN=CC=C2)C#N.

UNSPSC 51393702 Pelrinone, a Commodity code, appears in state and local procurement activity focused on pharmaceutical products and pharmacy benefit administration, though recent solicitations show limited direct alignment with pelrinone specifically. State and local governments are soliciting under related pharmaceutical-supply and health-services codes for naloxone distribution, drug deactivation systems, and pharmacy benefit management infrastructure. The issuing bodies range from county health departments to state health and human services agencies. Seminole County, Florida and the Texas Health and Human Services Commission represent the mix of jurisdictional buyers—county-level public health procurement alongside state-level pharmacy administration and policy development.

Recent activity includes Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually, posted June 30, 2026, with response due July 26, 2023 (note: date discrepancy in source), requiring quarterly deliveries to the county community health building and fixed-fee pricing; and the Texas Health and Human Services Commission's Request for Information HHS0017013 posted April 3, 2026, seeking vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. Geographic activity centers on Florida and Texas. The Seminole County solicitation emphasizes pharmaceutical supply and logistics; the Texas RFI targets pharmacy benefit program innovation and cost management. Neither opportunity explicitly names pelrinone procurement, suggesting the code may see limited current state and local activity or may be tagged in records that do not reflect typical buying patterns under this Commodity designation.